| 1 | FRGS: Human Norovirus Replication In A Novel 3D Culture System Via Toll-Like Receptor (TLRs) Pathway And Modulation By Commensal Intestinal Bacteria Principal Investigator: Assoc. Prof. Dr. Mudiana Muhamad Amount: RM 224,800. Duration:Dec 2019 – Jan 2023 (3 years) |
| 2 | FRGS: Mechanism of the enhancement of immune cells sensitization and trafficking in osteosarcoma by Spironolactone and Rosiglitazone towards adoptive immunotherapy in mice Principal Investigator: Assoc. Prof. Dr. Sharaniza Ab. Rahim Amount: RM 236,300. Duration:Jan 2019 – Dec 2022 (3 years) |
| 3 | FRGS: Investigating the role of eosinophils in the progression of breast cancer in mouse model post-radiotherapy treatment Principal Investigator: Dr. Mohammad Johari Ibahim Amount: RM 179,800. Duration:1st Sept 2019 – 31st Aug 2022 |
| 4 | FRGS: Investigating the role of eosinophils in the progression of breast cancer in mouse model post-radiotherapy treatment Principal Investigator: Mohammad Johari Ibahim Amount: RM 123,200. Duration: 1st August 2016 – 31st January 2020 |
| 5 | FRGS-RACER: Lapatinib-Induced Changes In Caco-2 Intestinal Monolayer And Intervention With Recombinant Epidermal Growth Factor Receptor (rEGFR) 600-IRMI/FRGS-RACER 5/3 (018/2019) Principal Investigator: Dr. Wan Nor I’zzah Wan Mohamad Zain Amount: RM 51,200.00. Duration:1st Sept 2019 – 31st Aug 2021 |
| 6 | Bestari Perdana: Effect of Bisphenol A on the small intestinal tight junction proteins claudin 2, 3 and 4 in pregnant rats and their fetuses. Principle invistigator: AP Dr. Jesmine Khan Amount: RM 30,000. Duration:1st Jan 2018 – 31st December 2019 |
| 7 | LESTARI: Protective and antimicrobial mechanisms of anti-tetraspanins peptides against pseudomonas aeruginosa adherence to human keratinocytes. Principle investigator: Dr. Emida Mohamed Amount: RM 30,000 Duration:1 Sept 2018 – 31st Aug 2020 |
| 8 | GIP: Role of eosinophils in the tumouregenic effect of breast cancer in mouse model post-radiotherapy treatment Principle investigator: Dr. Mohammad Johari Ibahim Amount: RM 25,000 Duration:1 Sept 2018 – 3 February 2020 |
| 8 | BESTARI: Investigation of eosinophil granule proteins gene expression in human breast cancer cell line resistant to gamma-ray irradiation: in vitro and vivo studies Principle investigator: Dr. Mohammad Johari Ibahim Amount: RM 35,000 Duration:1 January 2018 – 31 December 2019 |
